Abstract OT1-01-02: A multicenter phase II trial to evaluate the efficacy and safety of pembrolizumab and gemcitabine in patients with HER2-negative advanced breast cancer: GEICAM/2015-04 PANGEA-Breast

Multicenter phase II trial of gemcitabine plus liposomal doxorubicin in chemotherapeutically pretreated patients with advanced breast cancer (ABC

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.696 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 696-696

Author(s):

K. Haider ◽

G. Kornek ◽

W. Kwasny ◽

D. Depisch ◽

T. Payrits ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Advanced Breast ◽

Multicenter Phase ◽

Pretreated Patients

Run-in-phase results from a multicenter phase II trial to evaluate pembrolizumab (P) and gemcitabine (Gem) in patients (pts) with HER2-negative advanced breast cancer (ABC): GEICAM/2015-04 PANGEA-Breast

Annals of Oncology ◽

10.1093/annonc/mdy487.019 ◽

2018 ◽

Vol 29 ◽

pp. x32

Author(s):

V. Quiroga ◽

E. Holgado ◽

J.L. Alonso ◽

R. Andres ◽

F. Moreno Anton ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Breast ◽

Preliminary results of a multicenter phase II trial of neoadjuvant docetaxel, carboplatin and capecitabine for inflammatory and locally advanced breast cancer (LABC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.876 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 876-876 ◽

Cited By ~ 1

Author(s):

S. X. Franco ◽

A. Perez ◽

C. Frankel ◽

E. Tan-Chiu ◽

L. Schwartzberg ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Breast ◽

Preliminary Results ◽

A Multicenter Phase Ii Trial of Nab-Paclitaxel in Combination with Capecitabine in Patients (Pts) with Her-2 Negative and Triple Negative Advanced Breast Cancer (Abc): an Interim Analysis

Annals of Oncology ◽

10.1093/annonc/mdu329.20 ◽

2014 ◽

Vol 25 ◽

pp. iv123

Author(s):

M. Ciccarese ◽

L. Orlando ◽

P. Fedele ◽

P. Schiavone ◽

E. Maiello ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Interim Analysis ◽

Triple Negative ◽

Phase Ii Trial ◽

Advanced Breast ◽

Multicenter Phase ◽

Her 2

A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?

The Breast Journal ◽

10.1111/tbj.13856 ◽

2020 ◽

Vol 26 (9) ◽

pp. 1857-1859

Author(s):

Mariangela Ciccarese ◽

Laura Orlando ◽

Palma Fedele ◽

Paola Schiavone ◽

Evaristo Maiello ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Triple Negative ◽

Phase Ii Trial ◽

Advanced Breast ◽

Multicenter Phase ◽

Her 2

SAKK 21/12: A stratified, multicenter phase II trial of transdermal CR1447 in endocrine responsive-HER2 negative and triple negative-androgen receptor positive metastatic or locally advanced breast cancer

Annals of Oncology ◽

10.1093/annonc/mdz100.014 ◽

2019 ◽

Vol 30 ◽

pp. iii52

Author(s):

M.H.F. Vetter ◽

K. Rothgiesser ◽

Q. Li ◽

H. Hawle ◽

W. Schönfeld ◽

...

Keyword(s):

Breast Cancer ◽

Androgen Receptor ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Triple Negative ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Breast ◽

Multicenter phase II trial of gemcitabine plus liposomal doxorubicin in chemotherapeutically pretreated patients with advanced breast cancer (ABC

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.696 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 696-696

Author(s):

K. Haider ◽

G. Kornek ◽

W. Kwasny ◽

D. Depisch ◽

T. Payrits ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Advanced Breast ◽

Multicenter Phase ◽

Pretreated Patients

P91 Gemcitabine, epirubicin, and docetaxel (GED) asneoadjuvant therapy. Updated results from a multicenter phase II trial in locally advanced breast cancer

The Breast ◽

10.1016/s0960-9776(05)80127-4 ◽

2005 ◽

Vol 14 ◽

pp. S41

Author(s):

D. Yardley ◽

P. Whitworth ◽

F. Greco ◽

L. Dunbar ◽

H. Burris ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Breast ◽

A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer

Journal of Breast Cancer ◽

10.4048/jbc.2017.20.4.340 ◽

2017 ◽

Vol 20 (4) ◽

pp. 340

Author(s):

Ye Won Jeon ◽

Tae Hyun Kim ◽

Hyun Jo Youn ◽

Sehwan Han ◽

Yongsik Jung ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Advanced Breast ◽

Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer

Acta Oncologica ◽

10.1080/02841860600897868 ◽

2007 ◽

Vol 46 (2) ◽

pp. 208-213 ◽

Cited By ~ 7

Author(s):

Herbert Ulrich-Pur ◽

Gabriela V. Kornek ◽

Karin Haider ◽

Werner Kwasny ◽

Thomas Payrits ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Pegylated Liposomal Doxorubicin ◽

Advanced Breast ◽

Pretreated Patients